1. Market Research
  2. > Biotechnology
  3. > Biopharmaceutical Market Trends
  4. > Biopharmaceutical Analysis & Statistics, October 2016 (p10)

Biopharmaceutical Analysis & Statistics, October 2016 (p10)

24/7 Customer Support

Talk to Ahmad

+44 207 1931 362

271-300 of about 700 reports

Purchase Reports From Reputable Market Research Publishers

Post Menopausal Osteoporosis - Pipeline Review, H2 2016

  • € 1818
  • Company report
  • October 2016
  • by Global Markets Direct

Post Menopausal Osteoporosis - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Post Menopausal Osteoporosis - Pipeline Review, H2 2016, ...

  • Industries : Chronic Disease, Therapy, Pathology, Pharmaceutical
  • Countries : United States, World

Osteoporosis - Pipeline Review, H2 2016

  • € 1818
  • Company report
  • October 2016
  • by Global Markets Direct

Osteoporosis - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Osteoporosis - Pipeline Review, H2 2016, provides an overview of the ...

  • Industries : Chronic Disease, Pathology, Pharmaceutical, Therapy
  • Countries : United States, World

Febrile Neutropenia - Pipeline Review, H2 2016

  • € 1818
  • Company report
  • October 2016
  • by Global Markets Direct

Febrile Neutropenia - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Febrile Neutropenia - Pipeline Review, H2 2016, provides an overview ...

  • Industries : Therapy, Biopharmaceutical, Pharmaceutical
  • Countries : United States, World

Placenta Growth Factor (Vascular Endothelial Growth Factor Related Protein or PGF) - Pipeline Review, H2 2016

  • € 3182
  • Company report
  • October 2016
  • by Global Markets Direct

Placenta Growth Factor (Vascular Endothelial Growth Factor Related Protein or PGF) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Placenta Growth Factor (Vascular Endothelial Growth Facto ...

  • Industries : Health Services, Therapy, Pathology
  • Countries : United States

Gastric Cancer - Pipeline Review, H2 2016

  • € 1818
  • Company report
  • October 2016
  • by Global Markets Direct

Gastric Cancer - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Gastric Cancer - Pipeline Review, H2 2016, provides an overview of ...

  • Industries : Cancer, Pathology
  • Countries : United States

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • € 5045
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

  • Industries : Pharmaceutical, Drug Discovery and Development, Healthcare
  • Countries : World, Europe, Asia

Plaque Psoriasis (Psoriasis Vulgaris) - Pipeline Review, H2 2016

  • € 1818
  • Company report
  • October 2016
  • by Global Markets Direct

Plaque Psoriasis (Psoriasis Vulgaris) - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Plaque Psoriasis (Psoriasis Vulgaris) - Pipeline ...

  • Industries : Pathology, Healthcare, Pharmaceutical
  • Countries : United States

Gastroenteritis - Pipeline Review, H2 2016

  • € 1818
  • Company report
  • October 2016
  • by Global Markets Direct

Gastroenteritis - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Gastroenteritis - Pipeline Review, H2 2016, provides an overview of ...

  • Industries : Pathology, Therapy, Pharmaceutical
  • Countries : United States

Alliqua BioMedical, Inc. (ALQA) - Medical Equipment - Deals and Alliances Profile

  • € 227
  • Company report
  • October 2016
  • by GlobalData

Summary Alliqua BioMedical, Inc. (Alliqua BioMedical) formerly HepaLife Technologies Inc. is a medical device company that offers wound care solutions. The company offers wound care, transdermal drug delivery, ...

  • Industries : Biopharmaceutical

Arbutus Biopharma Corporation (ABUS) - Financial and Strategic SWOT Analysis Review

  • € 114
  • Company report
  • October 2016
  • by GlobalData

Arbutus Biopharma Corporation (ABUS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled ...

  • Industries : Biopharmaceutical

Industrial Enzymes Market by Type, Application, Source, and Region - Global Forecast to 2022

  • € 5045
  • Industry report
  • October 2016
  • by MarketsandMarkets

“Industrial enzymes market projected to grow at a CAGR of 5.8%.” The industrial enzymes market is projected to grow at a CAGR of 5.8% from 2017 and reach USD 6.30 billion by 2022. The demand for industrial ...

  • Industries : Biopharmaceutical, Biotechnology
  • Countries : World, Asia, Europe

Advanced Enzyme Technologies Ltd

  • € 90
  • Company report
  • October 2016
  • by Wright Investors' Service

A textual analysis of the financial results for Advanced Enzyme Technologies Ltd compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ...

  • Countries : World, India

Glycoprotein 41 (gp41) - Pipeline Review, H2 2016

  • € 3182
  • Company report
  • October 2016
  • by Global Markets Direct

Glycoprotein 41 (gp41) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Glycoprotein 41 (gp41) - Pipeline Review, H2 2016’, provides in depth analysis on Glycoprotein 41 (gp41) targeted ...

  • Industries : Therapy, Pathology, Pharmaceutical
  • Countries : United States

Hepatitis D - Pipeline Review, H2 2016

  • € 1818
  • Company report
  • October 2016
  • by Global Markets Direct

Hepatitis D - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Hepatitis D - Pipeline Review, H2 2016, provides an overview of the Hepatitis ...

  • Industries : Pathology
  • Countries : United States, World

Provectus Biopharmaceuticals, Inc. (PVCT) - Financial and Strategic SWOT Analysis Review

  • € 273
  • Company report
  • October 2016
  • by GlobalData

Summary Provectus Biopharmaceuticals, Inc. (Provectus), formerly Provectus pharmaceuticals, Inc. is a biopharmaceutical company that develops pharmaceuticals for oncology and dermatology indications. The ...

  • Industries : Biopharmaceutical
  • Countries : United States

Eiger BioPharmaceuticals, Inc. (EIGR) - Financial and Strategic SWOT Analysis Review

  • € 273
  • Company report
  • October 2016
  • by GlobalData

Summary Eiger BioPharmaceuticals, Inc. (Eiger) formerly Celladon Corporation is a clinical stage biopharmaceutical company that discovers and develops novel drugs for the treatment of orphan diseases. ...

  • Industries : Biopharmaceutical

Shin Nippon Biomedical Laboratories, Ltd. (2395) - Financial and Strategic SWOT Analysis Review

  • € 273
  • Company report
  • October 2016
  • by GlobalData

Summary Shin Nippon Biomedical Laboratories, Ltd. (SNBL) is a healthcare service provider that provides drug and clinical development service to biopharmaceutical companies. Its preclinical services include ...

  • Industries : Biopharmaceutical

European Erythropoietin Market Outlook 2022

  • € 1364
  • Industry report
  • October 2016
  • by RNCOS

Erythropoietin drugs are protein therapeutics, which is used to treat various types of anaemia. These drugs play a significant role in treating CKD related anaemia and cancer related anaemia. Since its ...

  • Industries : Biopharmaceutical
  • Countries : Europe

Theravance Biopharma, Inc. (TBPH) - Financial and Strategic SWOT Analysis Review

  • € 273
  • Company report
  • October 2016
  • by GlobalData

Summary Theravance Biopharma, Inc. (Theravance) which discovers and develops novel medicines for various diseases.It offers a commercial product, telavancin which is a dual mechanism antibiotic.The company’s ...

  • Industries : Biopharmaceutical

Alder Biopharmaceuticals Inc. (ALDR) - Financial and Strategic SWOT Analysis Review

  • € 273
  • Company report
  • October 2016
  • by GlobalData

Summary Alder Biopharmaceuticals Inc. (Alder) develops, produces and markets monoclonal antibody therapeutics for the treatment of migraine, Cushing’s disease and autoimmune and inflammatory diseases. ...

  • Industries : Biopharmaceutical

RedHill Biopharma Ltd. (RDHL) - Financial and Strategic SWOT Analysis Review

  • € 273
  • Company report
  • October 2016
  • by GlobalData

Summary RedHill Biopharma Ltd. (RedHill) is a biopharmaceutical company that focuses on the development and commercialization of small molecule drugs for the treatment of inflammatory and gastrointestinal ...

  • Industries : Biopharmaceutical

Single-use Bioprocessing Market by Product, Application, End User - Global Forecast to 2021

  • € 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

Rising Biopharmaceutical Demand and Increasing Investments in R&D Activities Drive Growth of the Single-use Bioprocessing Market The global single-use bioprocessing market is projected to reach USD 5.44 ...

  • Industries : Biopharmaceutical, Biotechnology
  • Countries : World, North America, Asia

Single-use Bioreactor Market by Product, Cell, Technology, Application, End User - Global Forecast to 2021

  • € 5045
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global single-use bioreactors market is projected to reach USD 1,085.7 million by 2021 from USD 408.4 million in 2016, growing at a CAGR of 21.6% during the forecast period (2016–2021). In this report, ...

  • Industries : Biopharmaceutical, Biotechnology
  • Countries : World, Europe, North America

Hemispherx Biopharma, Inc. (HEB) - Financial and Strategic SWOT Analysis Review

  • € 114
  • Company report
  • October 2016
  • by GlobalData

Hemispherx Biopharma, Inc. (HEB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled ...

  • Industries : Biopharmaceutical

Global Biosimilars Market and Forecast (By Product Type, Applications, Country Wise and Companies) to 2021 and Biosimilars Approved and Pipeline Analysis

  • € 1227
  • Industry report
  • October 2016
  • by Igate Research

The biosimilars are poised to capture an unprecedented position in the biopharmaceutical industry driven by an increased extent of adoption and growing investment and deal making activity globally. The ...

  • Industries : Biopharmaceutical, Generic Drug, Biotechnology, Pharmaceutical
  • Countries : World

Tangential Flow Filtration Market Product (Cassettes, Cartridges), Membrane Material (Polyethersulfone, Regenerated Cellulose), Technology (Ultrafiltration, Microfiltration), Pore Size (Ultrafilters), Application (Bioprocess) Global Forecast to 2021

  • € 5045
  • Industry report
  • October 2016
  • by MarketsandMarkets

The tangential flow filtration market is projected to reach USD 1,005.0 million by 2021 USD 554.7 million in 2016, growing at a CAGR of 12.6% during the forecast period (2016–2021). Growth in the bi ...

  • Industries : Biotechnology, Biopharmaceutical
  • Countries : North America, World

Lantus (Insulin Glargine) Biosimilar Clinical Trial & Opportunity Insight

  • € 909
  • Industry report
  • October 2016
  • by PNS Pharma

“Lantus (Insulin Glargine) Biosimilar Clinical Trial & Opportunity Insight” report by PNS Pharma gives comprehensive clinical insight on 37 biosimilar version of Lantus drug in clinical pipeline. Currently ...

  • Industries : Biopharmaceutical, Therapy

Humira Biosimilars Clinical Trial Insight

  • € 1364
  • Industry report
  • October 2016
  • by PNS Pharma

“Humira Biosimilars Clinical Trial Insight” report by PNS Pharma gives comprehensive clinical insight on 33 biosimilars version of Humira drug in clinical pipeline. More than 10 of these biosimilars ...

  • Industries : Therapy, Biopharmaceutical, Oncology
  • Countries : United States

Insulin Biosimilars - Global Market Outlook (2016-2022)

  • € 3922
  • Industry report
  • October 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Insulin Biosimilars market is accounted for $xx million in 2015 and is expected to reach $xx million by 2022 growing at a CAGR of xx% from 2015 to 2022. Growing ...

  • Industries : Biopharmaceutical, Generic Drug, Pharmaceutical
  • Countries : World, Asia, Europe, North America

Remicade (Infliximab) Biosimilar Clinical Trial Insight

  • € 1091
  • Industry report
  • October 2016
  • by PNS Pharma

“Remicade (Infliximab) Biosimilar Clinical Trial Insight” report by PNS Pharma gives comprehensive clinical insight on 17 biosimilar version of Remicade drug in clinical pipeline. Currently there are ...

  • Industries : Therapy

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.